Troy Tabaz, FDA’s top digital health official, announced that he is leaving the agency after two years leading the Digital Health Center of Excellence. He was the second director of the office, which was established in 2020. FDA has not announced a new acting director for DHCoE. As director of the Center for Excellence, Tabaz oversaw work on a variety of digital health initiatives and products, including launching FDA’s Predetermined Change Control Plan policy. Tabaz’s departure comes as the Trump...